A Study of Enasidenib in People With T-Cell Lymphoma
Clinical trial NCT06756308 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06756308
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-24
- Primary completion
- 2027-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.